Meng Li

Assistant Professor

University of Southern California

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Meng Li is an Assistant Professor at the University of Southern California. His research focuses on value assessment for health services and medical technologies, including cost-effectiveness analysis and disparities in cancer treatment. His recent publications address topics such as the adoption of immune checkpoint inhibitors and the financial implications of cancer treatments within Medicare. He is dedicated to advancing health equity and improving the societal value of innovations in healthcare.

Articles (11)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Collaborators (3)

Ya-Chen Tina Shih

Professor

University of California, Los Angeles

UNITED STATES

View details

Candice Hinkston

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Louis Garrison

Professor Emeritus

University of Washington

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Meng Li

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Value assessment for health services and procedures: a call to action in a new political climate

Generalized cost–effectiveness analysis: charting a path forward for measuring the societal value of medical technologies

Factors Associated with Adoption of Immune Checkpoint Inhibitor Treatment for Advanced Melanoma: A SEER-Medicare Cohort Study

The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations

Incorporating Real Option Value in Valuing Innovation: A Way Forward

Rural-Urban Disparities in Colorectal Cancer Screening, Diagnosis, Treatment, and Survivorship Care: A Systematic Review and Meta-Analysis

The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study

Disparity in checkpoint inhibitor utilization among commercially insured adult patients with metastatic lung cancer

Growing Financial Burden From High-Cost Targeted Oral Anticancer Medicines Among Medicare Beneficiaries With Cancer

Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer

Medicare Beneficiaries, Especially Unsubsidized Minorities, Struggle to Pay for Prescription Drugs: Results from the Medicare Current Beneficiary Survey

Collaborators (3)

Ya-Chen Tina Shih

Candice Hinkston

Louis Garrison

Make your next move.